Tonix Pharmaceuticals, Inc.
Clinical trials sponsored by Tonix Pharmaceuticals, Inc., explained in plain language.
-
Drug study in healthy volunteers: no cure, just data
Knowledge-focused CompletedThis early-stage study looked at how the drug TNX-102 SL (a muscle relaxant taken under the tongue) is absorbed and tolerated in 20 healthy Japanese and Chinese adults. Participants received two different doses to compare drug levels and safety. The goal was to gather information…
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New drug TNX-1500 tested in healthy people for first time
Knowledge-focused CompletedThis early-phase study tested the safety of a new drug called TNX-1500 in 26 healthy adults. Participants received either a single dose of the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. The goal was not to treat any disease,…
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC